GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Market Cap	2.13T
Revenue (ttm)	68.40B
Net Income (ttm)	-65.38B
Shares Out	42.08M
EPS (ttm)	-1,632.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	463,773
Average Volume	349,272
Open	49,250
Previous Close	50,700
Day's Range	45,900 - 49,500
52-Week Range	11,270 - 72,700
Beta	0.99
RSI	39.33
Earnings Date	Aug 14, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1998
• Employees: 182
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082270

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.